Return to homepagePandemic Pact

The Military HIV Research Program ( MHRP ) Clinical Trial Unit

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3UM1AI108568-09S1

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022
    2022

  • Known Financial Commitments (USD)

    $42,798

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    Julie Ake

  • Research Location

    United States of America

  • Lead Research Institution

    HENRY M. JACKSON FDN FOR THE ADV MIL/MED

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Abstract COVID-19 Vaccine Clinical Development Team The USG enterprise to develop and optimize vaccine prevention modalities for SARS CoV-2 incorporates the DAIDS HVTN as a key partner in strategic development, research prioritization and execution, landscape analysis for future directions and analysis of outcomes. Dr. Robb has co-chaired and participated in the USG Vaccine Development Team for clinical research along with the PI and others within the HVTN. The administrative amendment to CTU funding to HJF will sustain Dr. Robb's role in this capacity.